FBR analyst Vernon Bernardino met with Novavax, Inc. (NASDAQ:NVAX) management last week to discuss fundamentals and future 2017 clinical development.
The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for its pipeline cancer drug that sent shares rising. …
On December 22nd, Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) offered a progress update on its partnership with local Chinese partner, Guangdong Synergy Hydrogen, …
FBR analyst Vernon Bernardino came out with some commentary on Aurinia Pharmaceuticals Inc (NASDAQ:AUPH), after the drug maker announced it received meeting minutes for …
Chesapeake Energy Corporation (NYSE:CHK) announced yesterday that it has signed an agreement to sell a portion of its acreage and producing properties in its …
In a research report released Friday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Galena Biopharma Inc (NASDAQ:GALE), while adjusting …
Shares of Gap Inc (NYSE:GPS) lost over 10% of their value today after the fashion giant warned investors that store traffic will continue to …
FBR Capital analyst Christopher James weighed in with a few insights on Keryx Biopharmaceuticals (NASDAQ:KERX), after the drug maker announced that the FDA granted approval for …
In a research report released Friday, FBR Capital analyst Vernon Bernardino reiterated an Outperform rating on shares of Novavax, Inc. (NASDAQ:NVAX), with a price …
In a research report issued Thursday, FBR analyst Vernon Bernardino reiterated an Outperform rating on shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) with a price …
